Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Oragenics Inc. Common Stock (NY:OGEN)

0.1899 -0.0044 (-2.26%)
Streaming Delayed Price Updated: 3:01 PM EDT, May 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 111,288
Open 0.1910
Bid (Size) 0.1891 (6)
Ask (Size) 0.1900 (4)
Prev. Close 0.1943
Today's Range 0.1820 - 0.1942
52wk Range 0.1617 - 2.980
Shares Outstanding 21,475,289
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Secures Australian Approval to Launch Phase II Concussion Trial
Via Investor Brand Network
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) to Host May 20 Webinar on Concussion Drug Program ONP-002
Via Investor Brand Network

Performance

YTD
-47.2%
-47.2%
1 Month
+1.6%
+1.6%
3 Month
-32.9%
-32.9%
6 Month
-29.8%
-29.8%
1 Year
-92.4%
-92.4%

More News

Read More
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Top movers in Monday's after hours session
Via Chartmill
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Submits Protocol for Phase II Concussion Trial in New Zealand
Via Investor Brand Network
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Highlights Intranasal Drug Delivery at Boston Summit
Via Investor Brand Network
Wondering what's happening in today's after-hours session?
Via Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
InvestorNewsBreaks – Oragenics Inc. Highlights Q1 Milestones and Prepares for Concussion Drug Trial
Via Investor Brand Network
InvestorNewsBreaks – Oragenics Inc. Files 2024 Annual Report, Addresses Going Concern Status
Via Investor Brand Network
BioMedNewsBreaks — Oragenics Inc. Advances Concussion Treatment with Phase II Trial Preparation
Via Investor Brand Network
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Highlights Concussion Treatment Advances at Emergencies in Medicine Conference
Via Investor Brand Network
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Appoints Chief Medical Officer to Medical Board of The Leigh Steinberg Foundation
Via Investor Brand Network
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Partners With BRAINBox Solutions to Advance Concussion Care
Via Investor Brand Network
Most active stocks in Wednesday's session
Via Chartmill
What's going on in today's session
Via Chartmill
The market is filled with gapping stocks in Wednesday's session.
Via Chartmill
US Stocks Mixed; Walt Disney Posts Upbeat Earnings
Via Benzinga
These stocks are moving in today's pre-market session
Via Chartmill
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Chief Medical Officer to Speak at Brain Health Summit During Super Bowl Week
Via Investor Brand Network
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
What's going on in today's after hours session
Via Chartmill
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Advances ONP-002 Development, Appoints Janet Huffman as Interim CEO
Via Investor Brand Network
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Oragenics Inc. Common Stock publicly traded?
Yes, Oragenics Inc. Common Stock is publicly traded.
What exchange does Oragenics Inc. Common Stock trade on?
Oragenics Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Oragenics Inc. Common Stock?
The ticker symbol for Oragenics Inc. Common Stock is OGEN on the New York Stock Exchange
What is the current price of Oragenics Inc. Common Stock?
The current price of Oragenics Inc. Common Stock is 0.1899
When was Oragenics Inc. Common Stock last traded?
The last trade of Oragenics Inc. Common Stock was at 05/23/25 03:01 PM ET
What is the market capitalization of Oragenics Inc. Common Stock?
The market capitalization of Oragenics Inc. Common Stock is 4.08M
How many shares of Oragenics Inc. Common Stock are outstanding?
Oragenics Inc. Common Stock has 4M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.